The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
about
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeHaptoglobin genotype and its role in determining heme-iron mediated vascular diseasePharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Cardiovascular complications of type 1 diabetes: update on the renal link.Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse populationHaptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Preeclampsia and diabetes.The association of diabetes and dementia and possible implications for nondiabetic populations.Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy.The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetesIs it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Haptoglobin genotype and its role in diabetic cardiovascular disease.Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Antioxidant vitamins and their use in preventing cardiovascular diseaseEffect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection.Oxidative stress and response in relation to coronary artery disease in type 1 diabetes.Vitamin E and diabetic nephropathy in mice model and humans.Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.Changing the face of diabetic care with haptoglobin genotype selection and vitamin e.Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.α-Tocopherol Stereoisomers in Human Plasma Are Affected by the Level and Form of the Vitamin E Supplement Used.The Protective Effect of Antioxidants Consumption on Diabetes and Vascular ComplicationsMeta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.
P2860
Q24634553-4EFBDB9A-E47C-449F-AA8F-B036CFA59569Q26852155-A18CC966-9E11-4432-BD7F-F83FE93CFB03Q27332892-C1AC8D4E-7F8D-4F29-B38B-D98221B43EADQ30239971-72AA3352-4B69-45A3-A88E-54D35C6A0EB8Q33406987-31F43C3D-BB9E-4F19-B093-75A619624CE5Q34051581-62695EDB-A37A-420D-88E4-008F7DFA997AQ34219439-1831451C-81D3-4F33-B8C2-701EFF8D4740Q35051099-6A2E11EE-F4AA-4801-B23A-4876A89C32D8Q35619553-F8E8A99A-D5E5-45D1-BBBB-55ADD6BC2554Q36153702-7D84E509-67D5-49D6-8B27-0AE70141AF9AQ36600400-3D6F4A6B-BC1E-4FBC-8394-EE19E4B24105Q36664118-B79D44C3-9722-41CD-8DC5-93245332A2B2Q36678611-82E097FA-2B08-4B88-9141-31798CDC6F80Q36691768-4223A258-E415-4AFD-B3DF-A9F1AC4B55C8Q36700173-63B3DEA8-171A-4D62-9A3C-0A1EE33651C6Q36782847-DC2265B3-8E06-49FE-B6F6-67286C393913Q37076469-CB948498-6D48-4587-9EF1-040D4100D282Q37278164-E499BA9E-EDA3-44FD-8229-90E5785C9D81Q37322007-9AD1E2DB-0082-40CC-AB52-558515EC5EE5Q37385851-69FA831A-E043-471C-BE94-1DEDD8E1373CQ38126020-A10EBFEC-55FB-4D2F-A52B-ED80643E981EQ38815406-817FC74A-7F4E-4ED1-B57F-697E73706769Q40540495-2244C9AE-9EFD-4228-87F9-FAE7EC33BD1EQ40625705-1E39EA5F-9353-44C5-85CD-723C6CFE9203Q42226832-BF328E1A-5A56-4916-B454-98473F9E6E6AQ55294318-D9B5BC2B-CA0C-4D01-BD95-C70A0FFF5DD2
P2860
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@ast
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@en
type
label
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@ast
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@en
prefLabel
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@ast
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@en
P2093
P2860
P1433
P1476
The effect of vitamin E supple ...... ferent haptoglobin phenotypes.
@en
P2093
Andrew P Levy
Moshe Vardi
Nina S Levy
Rachel Miller-Lotan
Shany Blum
P2860
P356
10.1016/J.ATHEROSCLEROSIS.2010.02.018
P577
2010-02-21T00:00:00Z